Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Starting soon Not applicable

Effects of Intracanal Cryotherapy on Biomarkers and Postoperative Pain in Apical Periodontitis

NCT07850219 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-10
Last updated
2026-09-30

Condition(s) studied

Asymptomatic Apical Periodontitis

Investigational drug(s) / intervention(s)

Temperature-Controlled Intracanal Irrigation

Temperature-Controlled Intracanal Irrigation: Participants will receive temperature-controlled distilled-water intracanal irrigation during root canal treatment. According to computer-generated randomization, participants will be assigned to one of three irrigation-temperature groups: 2-4°C, 8-10°C, or 22-24°C. The assigned temperature-controlled distilled-water irrigation protocol will be applied during both treatment sessions. Irrigation conditions will be standardized across groups, with the irrigation temperature being the primary difference between the intervention groups.

Study summary

This randomized controlled clinical study will evaluate the effects of intracanal cryotherapy during root canal treatment in patients with asymptomatic apical periodontitis. The study will investigate whether the temperature of the final irrigation solution influences the biological inflammatory response and postoperative pain.

Participants will be randomly assigned to one of three groups according to the temperature of distilled water used for final root canal irrigation: 2-4°C, 8-10°C, or 22-24°C. Periapical tissue fluid samples will be collected before and after the intervention and analyzed for inflammatory and tissue-response biomarkers, including IL-1β, TNF-α, RANKL/OPG, PGE2, TGF-β, and MMP-9. Postoperative pain and analgesic use will also be recorded during the first 7 days after treatment.

The study aims to determine whether intracanal cryotherapy can reduce the inflammatory response and postoperative pain associated with root canal treatment and whether these effects vary according to the temperature of the irrigation solution.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Age between 18 and 65 years. * Presence of a posterior tooth indicated for primary endodontic treatment (excluding retreatment cases). * Diagnosis of apical periodontitis, meeting the following criteria: * Necrotic pulp based on pulp vitality testing (negative cold test and/or electrical pulp test \[EPT\]). * Periapical Index (PAI) ≥3 on periapical radiography or presence of periapical radiolucency on cone-beam computed tomography (CBCT). * Asymptomatic or mildly symptomatic apical periodontitis (excluding cases of severe acute apical periodontitis). * Periodontal status meeting the following criteria: * Probing depth ≤3 mm. * Clinical attachment loss ≤2 mm. * No periodontal pockets with bleeding on probing. * The tooth to be treated must be suitable for isolation and sample collection. * Participants must be able to understand the study procedures and provide informed consent. Exclusion Criteria: * Use of antibiotics, nonsteroidal anti-inflammatory drugs (NSAIDs), or -corticosteroids within the previous 3 months. * Presence of a systemic inflammatory or autoimmune disease. * Diabetes (glycated hemoglobin \[HbA1c\] ≥6.5%) or uncontrolled metabolic disease. * History of immunodeficiency or immunosuppressive therapy. * Pregnancy or breastfeeding. * Active smoking. * History of acute infection, febrile illness, or COVID-19 within the previous 3 -months. * Retreatment cases. * Presence of a fistula/sinus tract. * Periodontal probing depth \>3 mm. * Tooth mobility ≥ Grade II.

Primary outcome measure(s)

  • Change in Periapical Inflammatory Biomarker Levels — From the first treatment session to the second treatment session
    Changes in interleukin-1 beta (IL-1β), tumor necrosis factor-alpha (TNF-α), receptor activator of nuclear factor kappa-B ligand (RANKL), osteoprotegerin (OPG), prostaglandin E2 (PGE2), transforming growth factor-beta (TGF-β), and matrix metalloproteinase-9 (MMP-9) levels in periapical tissue fluid (PTF) will be assessed using enzyme-linked immunosorbent assay (ELISA). Biomarker levels obtained during the first and second treatment sessions will be compared within and between the three irrigation-temperature groups to evaluate the biological response to temperature-controlled intracanal irrigation.

Trial sites (1)

FacilityCityRegionStatus
Istanbul Medipol University Esenler SUAM Istanbul Turkey (Türkiye)
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07850219 on ClinicalTrials.gov ↗ ← All trials in Turkey